Physicians and the investment industry

JAMA

Volumn 293, Issue 21, 2005, Pages 2654-2657

  Topol, Eric J ^a,c   Blumenthal, David ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDUSTRY; INFORMATION DISSEMINATION; INVESTMENT; LAW; MEDICAL ETHICS; NOTE; PHYSICIAN; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; ARTICLE; BUSINESS ETHICS; CONFLICT OF INTEREST; ECONOMICS; ETHICS; HEALTH CARE AND PUBLIC HEALTH; HUMAN; INSTITUTIONAL ETHICS; ORGANIZATION; PUBLIC RELATIONS; UNITED STATES; UNIVERSITY HOSPITAL;

HEALTH CARE AND PUBLIC HEALTH;

ACADEMIC MEDICAL CENTERS; ACADEMIES AND INSTITUTES; CONFLICT OF INTEREST; ETHICS, BUSINESS; ETHICS, INSTITUTIONAL; HUMANS; INDUSTRY; INTERPROFESSIONAL RELATIONS; INVESTMENTS; PHYSICIANS; UNITED STATES;

EID: 19644382736     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.293.21.2654     Document Type: Note

References (17)

1. Gerson Lehrman Group. Interview with Mark Gerson, January 24, 2005. Available at: http://www.glgroup.com. Accessed April 28, 2005.
2. Gottleib S. Wall Street seeks doctors' medical advice on stocks. American Medical News. May 27, 2002. Available at http://www.ama-assn.org/amednews/2002/ 05/27/bicb0527.htm. Accessed April 28, 2005.
3. Bodow S. It's not what they know, but whom. New York Times. December 23, 2001;sect 3:8.
4. Leerink Swann & Co. Interview with Daniel Dubin, January 24, 2005. Available at: http://www.leerink.com. Accessed April 28, 2005.
5. Maler K. From simple to complex, hedge funds gain ground. New York Times. January 3, 2005:C14.
6. Anderson J, Atlas RD. If I only had a hedge fund. New York Times. March 27, 2005;sect 3:1.
7. Singer J. With rising clout, hedge funds start to sway mergers. Wall Street Journal. January 25, 2005:A1.
8. Partnoy F. Road rules for hedge funds. New York Times. December 15, 2004: A33.
9. Zuckerman G, Sender H. Ex-trader creates hot hedge fund, and a traffic jam. Wall Street Journal. January 12, 2005:A1.
10. Pricewaterhousecoopers/Thomson Venture Economics/National Venture Capital Association. Venture Capital Investment in Health Industries: Full Year and Q4 2004 Results. Available at: http://www.pwcmoneytree.com/exhibits/ Health_Industries_Report_Q4-Full_Year_2004.pdf. Accessibility verified April 27, 2005.
11. US General Accounting Office. Physician Workforce: Physician Supply Increased in Metropolitan and Nonmetropolitan Areas but Geographic Disparities Persisted. Washington, DC: US General Accounting Office; 2003:7.
12. Anand G, Smith R. Trial heat: biotech analysts strive to peek inside clinical tests of drugs. Wall Street Journal. August 8, 2002 :A1.
13. National Foundation for Cancer Research. Genomics Group Ties Biotech Firms to Investors. Available at: http://www2.nfcr.org/site/PageServer?pagename= press_genomicsbiofunding. Accessed April 28, 2005.
14. Zuckerman G, Anand G. The doctor is in and, increasingly, advising investors. Wall Street Journal. December 3, 2004:C1.
15. Blumenthal D. Academic-industrial relationships in the life sciences. N Engl J Med. 2003;349:2452-2458.
16. Blumenthal D. Doctors and drug companies. N Engl J Med. 2004;351:1885-1889.
17. Topol E. EricTopol responds. Fortune. December 27, 2004:24.